|
FDA Approval Activities for this Drug
Rescula (unoprostone isopropyl) Ophthalmic Solution, 0.15%, Ciba Vision NDA 21-214 8/3/00 8/28/00 8/28/00 7/18/01
Rescula Indications: for the lowering of intraocular pressure in patients with open-angel glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication. UNOPROSTONE ISOPROPYL Solution/Drops; Ophthalmic 0.15% RESCULA NOVARTIS
For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.
|